Advertisement

GI & Endoscopy

This article is sponsored by EndoChoice.The most revolutionary trends in gastrointestinal disease imaging, diagnostics and treatment cover the Institute for Healthcare Improvement's triple aim: improving patient experience of care, improving the health of patient populations and reducing the cost of…

Advertisement

Bedminster, N.J.-based NPS Pharmaceuticals completed a STEPS 2 study of Gattex, a treatment for patients with short bowel syndrome and found a large number of studied patients were able to completely or partially wean from parenteral support.

Advertisement